Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Pankreas
»
Neoplasms
08. April 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2982
Articles 1 - 20 / 59630
Dual role of exosomes in pancreatic cancer:Â Underlying mechanisms and research advances (Review).
Oncol Lett
Guo Z, Liu Q.
PMID: 41947900 [PubMed]
Development and validation of a nomogram for overall survival in pancreatic solid pseudopapillary neoplasm: a population-based study.
Sci Rep
Zhong P, Tao Q, Hu F.
PMID: 41946935 [PubMed - as supplied by publisher]
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States.
JAMA Netw Open
Hage Chehade C, Ozay ZI, Jo Y, Gebrael G, Sayegh N, Ostrowski M, Srivastava A, Garg D, Hardy T, Murdock EG, Narang A, Mathew Thomas V, Li H, Maughan BL, Roy S, Agarwal N, Swami U.
PMID: 41945343 [PubMed - indexed for MEDLINE]
Pancreatic cancer-associated myofibroblasts: a review.
Int J Biol Sci
Banacki M, Inkielewicz-Stepniak I.
PMID: 41943847 [PubMed - indexed for MEDLINE]
Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma.
J Mol Med (Berl)
Zhuang L, Zhang W, Wu J, Cao J, Feng L, Cao S.
PMID: 41942785 [PubMed - indexed for MEDLINE]
Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm.
Turk J Gastroenterol
Li W, Lin X, Liu P, Zhang J, Liu C.
PMID: 41942368 [PubMed - indexed for MEDLINE]
Impact of immunosuppressive therapy on non-melanoma skin cancer after solid organ transplantation: A critical systematic review.
Transpl Immunol
Abulail JA, Husein SA, Al-Tamimia M, Jaradat M, Alhawamdeh S, Elkhalili Z, Esaid R, Saleh T, Al Shboul S.
PMID: 41941970 [PubMed - as supplied by publisher]
pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic Cancer.
Pancreas
Martin RCG 2nd, Scheon E, Govindarajan N, Verdeur M, Justin J, Shamsi K.
PMID: 41941588 [PubMed - as supplied by publisher]
Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring.
Front Immunol
Zhao WY, Zhao JW.
PMID: 41939911 [PubMed - indexed for MEDLINE]
Correction: Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis.
Front Med (Lausanne)
Cretu OI, Lungulescu CV, Gentiluomo M, Turcu-Stiolica A, Pani, Patrascu S, Ungureanu BS.
PMID: 41939785 [PubMed]
Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions.
Front Oncol
Diao Z, Wang Y, Mu S, Wu X, Yu S, Wang Z.
PMID: 41939454 [PubMed]
Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms.
Front Endocrinol (Lausanne)
La Salvia A, Fanciulli G.
PMID: 41938105 [PubMed - indexed for MEDLINE]
Impact of Male Sex and Umbilical-Pancreatic Anatomy on Surgical Difficulty in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis.
Asian J Endosc Surg
Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Matsuhashi N.
PMID: 41936535 [PubMed - indexed for MEDLINE]
Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining.
Transl Oncol
Zhou J, Zeng T, Ye M, Li M, Wen L, Liu X, Zhang Z, Meng Y.
PMID: 41934917 [PubMed - as supplied by publisher]
Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives.
Trends Endocrinol Metab
Costamagna A, Milan G, De Santis MC, Carrer A, Martini M.
PMID: 41933959 [PubMed - as supplied by publisher]
Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer.
Crit Rev Oncol Hematol
Girolimetti G, Bramato G, Fiore A, Romano R, Guerra F, Bucci C, Basset A.
PMID: 41933855 [PubMed - as supplied by publisher]
Demographic and Prognostic Significance of Surgically-Treated Intrathyroidal Thymic Carcinoma: A Systematic Review and Meta-Analysis.
World J Surg
Jenkins CR, Hajibandeh S, Hajibandeh S, Scott-Coombes DM, Egan RJ.
PMID: 41931541 [PubMed - as supplied by publisher]
Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis.
Eur J Cancer
Filis P, Markozannes G, Salgkamis D, Tsiknakis N, Zerdes I, Pagkalidou E, Manou M, Filis N, Papakonstantinou A, Mavroudis D, Matikas A, Tsilidis KK, Foukakis T.
PMID: 41930854 [PubMed - as supplied by publisher]
Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.
Oncol Res
Wang S, Wang M, Yao W.
PMID: 41930147 [PubMed - indexed for MEDLINE]
Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review.
Cureus
Hussain F, Huba M, Paracha A, Kwait B, Siddiqui Z, Patel H, Lee A, Patel H, Palati S, Papale A, Copeland-Halperin RS, King D.
PMID: 41930062 [PubMed]
Articles 1 - 20 / 59630
Page 1 of 2982
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy